We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioFire Diagnostics

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based ... read more Featured Products: More products

Download Mobile App




Rapid Methods Compared for Positive Blood Cultures

By LabMedica International staff writers
Posted on 20 May 2014
The need for rapid antibiotic treatment of sepsis is well recognized, and the time to implementation of appropriate antibiotic therapy is critical in improving the outcome of sepsis.

Several methods have been developed to identify pathogens and some antibiotic resistance genes directly from positive blood culture bottles, which can shorten the time for final identification and susceptibility by as much as one to two days.

Medical laboratory scientists at the University of Florida (Gainesville, FL, USA) directly compared a multiplex polymerase chain reaction (PCR) method with a mass spectrometry system to identify organisms in positive blood cultures, between October 2012 and May 2013. More...
They analyzed fluid from 161 positive blood cultures by both methods within 2 to 12 hours of the time the culture signaled positive in BacTec plus aerobic/F bottles incubated in a BacTec 9240 instrument (Becton, Dickinson and Company; Franklin Lakes, NJ, USA).

The two methods used to identify the bacteria were the FilmArray Direct from Positive Blood Culture system (BCID) (BioFire Diagnostics, Salt Lake City, UT, USA) and the VITEK Mass Spectrometry System (Vitek MS, bioMérieux; Durham, NC, USA). The BCID uses multiplex PCR to identify 90% to 95% of common isolates to the genus or species/complex level as well as three antibiotic resistance genes in approximately one hour. The prepared slides for the Vitek MS system were run in a bioMérieux mass spectrometer (Marcy l’Etoile, France).

A total of 132/133 (99%) of isolates that were in the FilmArray panel were identified correctly to the genus and/or species level. For those organisms that the FilmArray could identify to the species or species/complex level, 84/84 (100%) were correctly identified; for those that would only be expected to be identified to the genus level, 48/49 (98%) were identified correctly. The turnaround time for an individual FilmArray test is about an hour and if multiple samples need to be run, multiple instruments may be necessary.

Mass spectrometry correctly identified 142/151 (94%) monomicrobic cultures to the genus level and 137/151 (91%) to the species level. Vitek MS can process up to 48 specimens per slide in approximately an hour, but the actual time to perform a direct identification from a positive blood culture bottle would depend both on the filtration time and the workflow in the clinical microbiology setting to set up the slide and be read in the mass spectrometer.

The authors concluded that both the FilmArray and the VITEK MS mass spectrometry systems were highly accurate and can provide results in about an hour after blood cultures become positive, but the FilmArray is far easier to perform and to incorporate into laboratory workflow. The study was published online on March 22, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of Florida
Becton, Dickinson and Company
BioFire Diagnostics



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Enterovirus Test
Quanty Enterovirus System
New
Biochemistry Analyzer
Chemi+ 8100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The precision oncology test identifies patients most at risk of undergoing severe toxicity from treatment with 5FU/capecitabine (Photo courtesy of 123RF)

Precision Oncology Test Predicts Patient Toxicity Before Beginning Chemotherapy

5-fluorouracil (5FU) and capecitabine have been cornerstone chemotherapeutic agents for over four decades, effectively treating a variety of cancers. However, 5FU/capecitabine can cause varying degrees... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Mimix Reference Standards are cell-line derived to maintain genomic complexity and mimic patient material across molecular diagnostics workflows (Photo courtesy of Revvity)

New Cancer Testing Standards to Improve Diagnostic Accuracy for Oncology Labs

Accurate diagnosis, including the identification of genomic markers, is essential for determining the most effective cancer treatments for patients. To ensure this, laboratories require reliable reference... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.